Balsa J A, Cacicedo L, Lara J I, Lorenzo M J, Pazos F, Sanchez-Franco F
Servicio de Endocrinologia, Hospital Ramón y Cajal, Madrid, Spain.
Endocrinology. 1996 Jan;137(1):144-50. doi: 10.1210/endo.137.1.8536606.
Several in vitro studies have demonstrated that vasoactive intestinal peptide (VIP) modulates basal PRL release in normal and hypothyroid anterior pituitary (AP) cells through an autocrine or paracrine action. As thyroid hormone is an important factor in the regulation of pituitary VIP synthesis and secretion, we analyzed the influence of the absence of thyroid hormone on basal PRL release in vitro to study whether the release of PRL induced by TRH might be mediated by a local action of pituitary VIP. When normal AP cells were cultured in a medium supplemented with a near-physiological concentration of free T2 (0.5 nM), basal PRL and VIP release decreased and PRL secretion was not altered by the blockade of VIP action. This finding allowed us to establish the culture conditions in which basal PRL secretion is apparently not under VIP influence. Consequently, we were able to study whether pituitary VIP may be implicated in TRH-induced PRL release. TRH (100 nM) increased PRL and VIP release in a parallel manner and decreased PRL and VIP intracellular content in incubations from 15-180 min. When AP cells wee incubated simultaneously with TRH and a VIP receptor antagonist, TRH-induced PRL release decreased when incubation lasted more than 30 min, whereas the depletion of PRL intracellular content induced by TRH was unchanged. TRH also slightly increased VIP messenger RNA levels at 3 and 24 h, but PRL messenger RNA levels were not modified. These data demonstrate that pituitary VIP participates in in TRH-induced PRL release and that the effect of thyroid hormone on basal pituitary VIP secretion should be borne in mind when studies on its effect, through autocrine and/or paracrine mechanisms, on PRL release stimulated by PRL-releasing factors are conducted.
多项体外研究表明,血管活性肠肽(VIP)通过自分泌或旁分泌作用调节正常及甲状腺功能减退的垂体前叶(AP)细胞基础PRL释放。由于甲状腺激素是调节垂体VIP合成与分泌的重要因素,我们分析了甲状腺激素缺乏对体外基础PRL释放的影响,以研究TRH诱导的PRL释放是否可能由垂体VIP的局部作用介导。当正常AP细胞在补充了接近生理浓度游离T2(0.5 nM)的培养基中培养时,基础PRL和VIP释放减少,VIP作用被阻断时PRL分泌未改变。这一发现使我们能够建立基础PRL分泌显然不受VIP影响的培养条件。因此,我们能够研究垂体VIP是否参与TRH诱导的PRL释放。TRH(100 nM)以平行方式增加PRL和VIP释放,并在15 - 180分钟的孵育中降低PRL和VIP细胞内含量。当AP细胞与TRH和VIP受体拮抗剂同时孵育时,孵育持续超过30分钟时TRH诱导的PRL释放减少,而TRH诱导的PRL细胞内含量消耗未改变。TRH在3小时和24小时时也轻微增加VIP信使RNA水平,但PRL信使RNA水平未改变。这些数据表明垂体VIP参与TRH诱导的PRL释放,并且在通过自分泌和/或旁分泌机制研究其对PRL释放因子刺激的PRL释放的作用时,应考虑甲状腺激素对垂体基础VIP分泌的影响。